Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.
Be the first to review this report.
EBUS (endobronchial ultrasound) bronchoscopy is a procedure used to diagnose different types of lung disorders, including inflammation, infections or cancer. Performed by a pulmonologist, EBUS bronchoscopy uses a flexible tube that goes through your mouth and into your windpipe and lungs. Similar to, though smaller than, the device used during a colonoscopy, the EBUS scope has a video camera with an ultrasound probe attached to create a local images of your lungs and nearby lymph nodes in order to accurately locate and evaluate areas seen on x-rays or scans that need a closer look.
The main companies of Global Endobronchial Ultrasound Biopsy include Olympus, Boston Scientific, CONMED, MEDI-GLOBE, Cook Medical, etc. These top five companies hold a market share about 65%. North America and Japan are the major producing regions in the world. In terms of application, the product is most widely used in hospitals, followed by ambulatory surgical centers.
This report provides an overview of the global Endobronchial Ultrasound Biopsy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Endobronchial Ultrasound Biopsy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Endobronchial Ultrasound Biopsy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Endobronchial Ultrasound Biopsy market.
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endobronchial Ultrasound Biopsy industry.
Chapter 3: Detailed analysis of Endobronchial Ultrasound Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Endobronchial Ultrasound Biopsy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Endobronchial Ultrasound Biopsy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
You may also be interested in
